CSI Market
Sign In | Register

Bionovate Technologies (BIIO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BIIO Annual Balance Sheets →
This page allows investors to track Bionovate Technologies's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2021)
(Jun 30 2021) (Mar 31 2021) (Dec 31 2020) (Sep 30 2020)
Assets
Cash & Short-term Investments0.00
Total Current Assets0.00
Total Assets0.00
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.29
Other Liabilities, Current0.24
Total Current Liabilities0.52
Convertible Notes Payable NO0.00
Total Long-term Debt0.00
Total Liabilities0.52
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock2.30
Retained Earnings / Accumulated Deficit-2.83
Other Equity0.00
Common Stockholder's Equity-0.52
Total Stockholder's Equity-0.52
4 historic quarters locked

Sign in to unlock the full Bionovate Technologies balance sheet history.

Sign In Create Free Account

About BIIO Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.